Bengaluru, India

Selvakumar Kumaravel

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 10.9

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • Karnataka, IN (2016)
  • Bengaluru, IN (2016 - 2021)

Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Selvakumar Kumaravel

Introduction

Selvakumar Kumaravel is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of treatments for human immunodeficiency virus (HIV) infection. With a total of seven patents to his name, Kumaravel's work has had a substantial impact on medical research and treatment options.

Latest Patents

Kumaravel's latest patents focus on inhibitors of human immunodeficiency virus replication. These patents include compounds of Formula I, which encompass pharmaceutically acceptable salts and compositions aimed at treating HIV infection. His innovative approach in this area showcases his commitment to advancing healthcare solutions.

Career Highlights

Throughout his career, Kumaravel has worked with notable companies such as Bristol-Myers Squibb Company and ViiV Healthcare UK (No. 5) Limited. His experience in these esteemed organizations has allowed him to hone his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Kumaravel has collaborated with several professionals in his field, including Upender Velaparthi and Mark D. Wittman. These partnerships have facilitated the exchange of ideas and fostered innovation in their shared pursuits.

Conclusion

Selvakumar Kumaravel's contributions to the field of HIV treatment through his patents and collaborations highlight his role as a key innovator in pharmaceutical sciences. His work continues to inspire advancements in medical research and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…